dibenzofuran-1-yl-methanol | 96706-47-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并呋喃
• 英文名称: dibenzofuran-1-yl-methanol
• 英文别名: 1-Dibenzofuranmethanol；dibenzofuran-1-ylmethanol
• CAS: 96706-47-7
• 化学式: C₁₃H₁₀O₂
• 分子量: 198.221
• InChiKey: QCMJNPCBOOXNRR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  33.4
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
  申请人：Lesur Brigitte

  公开号：US20050282821A1

  公开（公告）日：2005-12-22

  The present invention is related to chemical compositions, processes for the preparation thereof and uses of the composition. Particularly, the present invention relates to compositions of compounds of Formula (A): wherein Ar, Y, R 1 and q are as defined herein; and their use in the treatment of diseases, including treatment of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, treatment of attention deficit hyperactivity disorder (“ADHD”), enhancing function in disorders associated with hypofunctionality of the cerebral cortex, including, but not limited to, depression, schizophrenia, fatigue, in particular, fatigue associated with neurologic disease, such as multiple sclerosis, chronic fatigue syndrome, and improvement of cognitive dysfunction.

  本发明涉及化学组合物、其制备方法及组合物的用途。特别地，本发明涉及式（A）化合物的组合物：其中Ar、Y、R1和q如本文所定义；以及它们在治疗疾病中的应用，包括治疗嗜睡症、促进清醒、治疗帕金森病、脑缺血、中风、睡眠呼吸暂停、进食障碍、促进食欲和体重增加、治疗注意力缺陷多动障碍（“ADHD”）、增强与大脑皮层低功能相关的疾病的功能，包括但不限于抑郁症、精神分裂症、疲劳，特别是与神经系统疾病如多发性硬化症、慢性疲劳综合症相关的疲劳以及改善认知功能。
• THIO-SUBSTITUTED TRICYCLIC AND BICYCLIC AROMATIC METHANESULFINYL DERIVATIVES
  申请人：Lesur Brigitte

  公开号：US20090105241A1

  公开（公告）日：2009-04-23

  The present invention is related to chemical compositions, processes for the preparation thereof and uses of the composition. Particularly, the present invention relates to compositions of compounds of Formula (A): wherein Ar, Y, R 1 and q are as defined herein; and their use in the treatment of diseases, including treatment of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, treatment of attention deficit hyperactivity disorder (“ADHD”), enhancing function in disorders associated with hypofunctionality of the cerebral cortex, including, but not limited to, depression, schizophrenia, fatigue, in particular, fatigue associated with neurologic disease, such as multiple sclerosis, chronic fatigue syndrome, and improvement of cognitive dysfunction.

  本发明涉及化学组成物、其制备方法和组成物的用途。特别地，本发明涉及式（A）化合物的组成物：其中Ar、Y、R1和q如此定义；以及它们在治疗疾病中的应用，包括治疗嗜睡、促进清醒、治疗帕金森病、脑缺血、中风、睡眠呼吸暂停、进食障碍、刺激食欲和增重、治疗注意力缺陷多动障碍（“ADHD”）、增强与大脑皮层功能低下相关的疾病的功能，包括但不限于抑郁症、精神分裂症、疲劳，特别是与神经系统疾病相关的疲劳，如多发性硬化症、慢性疲劳综合征，以及改善认知功能。
• US7119214B2
  申请人：——

  公开号：US7119214B2

  公开（公告）日：2006-10-10
• US7476690B2
  申请人：——

  公开号：US7476690B2

  公开（公告）日：2009-01-13
• US7772237B2
  申请人：——

  公开号：US7772237B2

  公开（公告）日：2010-08-10